Psychomotorisches Syndrom Katatonie

Translated title of the contribution: Catatony - A psychomotor syndrome

Research output: Contribution to journalArticle

Abstract

At present, catatony can no longer be considered as an exclusive subgroup of schizophrenia, but also a psychomotor syndrome which may occur in case of most various diseases (psychiatric, neurologic, internal). The catatonic syndrome is distinguished by a characteristic combination of motory symptoms with behavioural peculiarities and psychic alterations. In differential diagnosis, it is difficult to distinguish the catatonic syndrome from malignant neuroleptic syndrome (MNS), for other locomotor disorders caused by neuroleptics and from extrapyramidal locomotor disorders. In therapy Lorazepam proves to be effective in 60-80% of the catatonic patients as far as the removal of the catatonic symptoms is concerned. In case of a resistance to therapy and life-threatening febrile catatonic conditions, amantadine therapy and/or electro-convulsive treatments have to be taken into consideration.

Original languageGerman
JournalTW Neurologie Psychiatrie
Volume11
Issue number6
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Basal Ganglia Diseases
Neuroleptic Malignant Syndrome
Lorazepam
Amantadine
Behavioral Symptoms
Therapeutics
Nervous System
Antipsychotic Agents
Psychiatry
Schizophrenia
Differential Diagnosis
Fever

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuropsychology and Physiological Psychology

Cite this

Psychomotorisches Syndrom Katatonie. / Northoff, G.

In: TW Neurologie Psychiatrie, Vol. 11, No. 6, 1997.

Research output: Contribution to journalArticle

@article{7210bf86e9b04e24bab26d0138cbc629,
title = "Psychomotorisches Syndrom Katatonie",
abstract = "At present, catatony can no longer be considered as an exclusive subgroup of schizophrenia, but also a psychomotor syndrome which may occur in case of most various diseases (psychiatric, neurologic, internal). The catatonic syndrome is distinguished by a characteristic combination of motory symptoms with behavioural peculiarities and psychic alterations. In differential diagnosis, it is difficult to distinguish the catatonic syndrome from malignant neuroleptic syndrome (MNS), for other locomotor disorders caused by neuroleptics and from extrapyramidal locomotor disorders. In therapy Lorazepam proves to be effective in 60-80{\%} of the catatonic patients as far as the removal of the catatonic symptoms is concerned. In case of a resistance to therapy and life-threatening febrile catatonic conditions, amantadine therapy and/or electro-convulsive treatments have to be taken into consideration.",
author = "G. Northoff",
year = "1997",
language = "德语",
volume = "11",
journal = "Therapie und Erfolg Neurologie Psychiatrie",
issn = "0935-3224",
publisher = "Braun",
number = "6",

}

TY - JOUR

T1 - Psychomotorisches Syndrom Katatonie

AU - Northoff, G.

PY - 1997

Y1 - 1997

N2 - At present, catatony can no longer be considered as an exclusive subgroup of schizophrenia, but also a psychomotor syndrome which may occur in case of most various diseases (psychiatric, neurologic, internal). The catatonic syndrome is distinguished by a characteristic combination of motory symptoms with behavioural peculiarities and psychic alterations. In differential diagnosis, it is difficult to distinguish the catatonic syndrome from malignant neuroleptic syndrome (MNS), for other locomotor disorders caused by neuroleptics and from extrapyramidal locomotor disorders. In therapy Lorazepam proves to be effective in 60-80% of the catatonic patients as far as the removal of the catatonic symptoms is concerned. In case of a resistance to therapy and life-threatening febrile catatonic conditions, amantadine therapy and/or electro-convulsive treatments have to be taken into consideration.

AB - At present, catatony can no longer be considered as an exclusive subgroup of schizophrenia, but also a psychomotor syndrome which may occur in case of most various diseases (psychiatric, neurologic, internal). The catatonic syndrome is distinguished by a characteristic combination of motory symptoms with behavioural peculiarities and psychic alterations. In differential diagnosis, it is difficult to distinguish the catatonic syndrome from malignant neuroleptic syndrome (MNS), for other locomotor disorders caused by neuroleptics and from extrapyramidal locomotor disorders. In therapy Lorazepam proves to be effective in 60-80% of the catatonic patients as far as the removal of the catatonic symptoms is concerned. In case of a resistance to therapy and life-threatening febrile catatonic conditions, amantadine therapy and/or electro-convulsive treatments have to be taken into consideration.

UR - http://www.scopus.com/inward/record.url?scp=0030769448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030769448&partnerID=8YFLogxK

M3 - 文章

AN - SCOPUS:0030769448

VL - 11

JO - Therapie und Erfolg Neurologie Psychiatrie

JF - Therapie und Erfolg Neurologie Psychiatrie

SN - 0935-3224

IS - 6

ER -